Protection against lethal influenza virus challenge by RNA interference in vivo. - Wikidata - wikimedia - TriplyDB

Protection against lethal influenza virus challenge by RNA interference in vivo.

Protection against lethal influenza virus challenge by RNA interference in vivo.

http://www.wikidata.org/entity/Q34514565

about

The 3' splice site of influenza A segment 7 mRNA can exist in two conformations: a pseudoknot and a hairpin The influenza virus enigma Current and future antiviral therapy of severe seasonal and avian influenza Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA.Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections Small Non-coding RNAs Associated with Viral Infectious Diseases of Veterinary Importance: Potential Clinical Applications Image-Guided Hydrodynamic Gene Delivery: Current Status and Future Directions Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance Silencing Viral Infection Delivery of RNAi Therapeutics to the Airways-From Bench to Bedside Current prospects for RNA interference-based therapies Influenza: old and new threats Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems Pandemic and seasonal influenza: therapeutic challenges Cost-effective approaches to influenza prevention and treatment.Novel strategies for prevention and treatment of influenza.Antiviral therapy of influenza.Drugs in development for influenza.Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication.In vitro RNA interference targeting the DNA polymerase gene inhibits orf virus replication in primary ovine fetal turbinate cells.Advances in Systemic siRNA Delivery Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection Drug delivery-mediated control of RNA immunostimulation A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease.Double-stranded RNA induces sequence-specific antiviral silencing in addition to nonspecific immunity in a marine shrimp: convergence of RNA interference and innate immunity in the invertebrate antiviral response?New treatments for influenza Non-cell autonomous RNA silencing.Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.Inhibition of influenza virus production in virus-infected mice by RNA interference.Development of resistance to RNAi in mammalian cells MicroRNA miR-320a and miR-140 inhibit mink enteritis virus infection by repression of its receptor, feline transferrin receptor.Combination of specific single chain antibody variable fragment and siRNA has a synergistic inhibitory effect on the propagation of avian influenza virus H5N1 in chicken cells.Cellular microRNA miR-181b inhibits replication of mink enteritis virus by repression of non-structural protein 1 translation.siRNA for Influenza Therapy.Possibilities for RNA interference in developing hepatitis C virus therapeutics.Development of gene-specific double-stranded RNA drugs.Polycation-mediated delivery of siRNAs for prophylaxis and treatment of influenza virus infection.Efficient inhibition of HIV-1 replication by an artificial polycistronic miRNA construct.The therapeutic potential of RNA interference.

P2860

Q21134545-0BD6C33A-E068-48DE-9628-4F7FC379DEF6 Q24616614-B9DD4B45-10B3-4B8D-BA2C-E06F147756BD Q24656164-0146181F-670B-4DC2-AEE5-0D7607578EE0 Q24675029-975945A3-3353-45EC-8BAC-D8263CB0038F Q24816212-CD328B6F-1706-41AF-866B-1F6D5B963662 Q26749578-8942125F-9BCD-4B88-85D0-F4BE721DF6EE Q26752417-121A34E2-CA6B-40F6-86E3-8ACC250E248A Q26797323-6E2EEB47-6E3A-4304-A1E0-F9AE21BD69AE Q27316994-71DB3D27-B4D5-4D27-B214-2C5C7B042A22 Q27473399-D5080E1E-C06F-4636-85BE-8651650CF88C Q28067306-2BD88BF0-DD66-4C38-A801-B066E3478718 Q28235733-9C36BC21-4124-4A21-8A9D-82C5D1B7D43E Q28296381-C9885A5C-2348-4C29-ABFB-D43C7B5C6E17 Q28392004-69AE2B47-3DA4-47DA-9C39-73CD545C239B Q30228856-C27121FA-D727-4357-858C-C4E82F8C87C0 Q30233084-5CA15FC4-4FCD-4B2F-AA36-2243E6D1A61E Q30350342-AE0049F7-8FFC-4D2E-AB0B-E14A42B9AF16 Q30350565-BF9625C8-15BF-4EE6-BDF1-0B19699D47C3 Q30391218-108600DE-F43C-458B-B574-46C57A68BC8B Q33455759-AB17236F-920B-446C-98CB-4DA966B8D54E Q33569123-32AB0041-040B-4FB7-B601-002D290A9841 Q33613316-C3BAAB2E-979A-40D6-B31B-BC73324E7F0F Q33669734-45611981-1FD1-4098-A9EE-6F0DD813E774 Q33713938-1F930C9E-2E25-490E-B68B-628933177651 Q34081491-2729DABD-0F09-4A06-B4A6-88CC7D44A1FF Q34092648-5B515F61-362D-44F8-9C18-94303C86A5EC Q34413797-39B7B3D5-32C0-41D3-B55A-CBCD6519B4B2 Q34461787-B4EBC6A3-99CE-40A6-A7F4-1E68AAFC20C6 Q34496721-F12369F7-2D20-4B36-9082-87BDC02CC5E5 Q34514513-83378A20-1C10-4A68-BD07-4BD125C33052 Q34619725-04C98C18-7C0B-4D03-AB0B-23A1351D8229 Q34686537-DEDDC1A3-1B6C-4CF9-B634-92076A892F2C Q34686635-0BF13F3F-F57F-4FCE-9FA8-E22D97C10296 Q35069646-B8BCCB41-EA98-4CAC-9440-B5232F26F52F Q35261103-92519048-9588-4BE1-94F3-7B7ECF72419C Q35261143-DEEB7743-F1AA-46DC-9195-1C026A51A995 Q35932393-91C8B280-C568-4DAD-B59D-ED92135C202E Q36150428-A8619077-BA9F-496F-9C6D-F4869DD8D605 Q36156552-B2417ACA-12B6-4BE3-8476-F711BA65F43F Q36237868-69F6929B-5206-4D09-93B3-3ECDC1C84594

P2860

Protection against lethal influenza virus challenge by RNA interference in vivo.

http://www.wikidata.org/entity/Q34514565

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Protection against lethal influenza virus challenge by RNA interference in vivo.

@ast

Protection against lethal influenza virus challenge by RNA interference in vivo.

@en

Protection against lethal influenza virus challenge by RNA interference in vivo.

@nl

type

label

Protection against lethal influenza virus challenge by RNA interference in vivo.

@ast

Protection against lethal influenza virus challenge by RNA interference in vivo.

@en

Protection against lethal influenza virus challenge by RNA interference in vivo.

@nl

prefLabel

Protection against lethal influenza virus challenge by RNA interference in vivo.

@ast

Protection against lethal influenza virus challenge by RNA interference in vivo.

@en

Protection against lethal influenza virus challenge by RNA interference in vivo.

@nl

P1433

Q34514565-EC54161A-4DE6-416D-B668-D582F3C44A86

P1476

Q34514565-A0E9B4A0-E6DF-4939-9AE9-26C8B02C6A75

P2093

Q34514565-47BCCC7E-30AC-4198-A5A8-61A7E7214A0F

Q34514565-A8232A31-C6FD-4D48-8C7A-847684E8796A

P2860

Q34514565-00C13850-D950-431E-984F-D39900C3735A

Q34514565-0436AD3A-2993-422C-9E71-2CE72C33BD5A

Q34514565-04C545ED-4EDD-454C-AD8A-A8257102E9E7

Q34514565-09591810-EA07-4F16-8D9A-DB06608D7555

Q34514565-25D4EDC3-07B7-4C3E-99BE-2518CF7676CE

Q34514565-2CC42157-3CC3-4B51-8FCC-68053CC5E94A

Q34514565-30E53934-FF00-4BDC-918D-CEB1C0341C0C

Q34514565-332B9797-20B5-4B4F-839B-0C0F5AD6FC9B

Q34514565-384833A6-BDB1-485F-B9A7-4D7EBB0B35F6

Q34514565-3B671197-0881-4B8A-8076-817498667DC6

P304

Q34514565-CDDB4123-43D6-497F-BCBD-AF20E3F0BE47

P31

Q34514565-E40D72B0-5575-42E9-967D-90C8F6158DC8

P356

Q34514565-AAA54A70-3E5D-4FFE-B40A-785E92417CBA

P407

Q34514565-FD072C5D-362D-41A4-9880-1BB553E19C52

P433

Q34514565-88195AD7-6B5F-4626-924C-4F4EF5C0AB0D

P478

Q34514565-82C5A74B-26DA-432D-8F0C-07329F0F5788

P50

Q34514565-6801CF3C-613A-4C21-8D31-2AB490AB953B

Q34514565-73069D6B-6976-489D-AFC5-D3BA0F80A3D5

P577

Q34514565-4C61F8EF-71E4-403E-9F79-9C68F5F580E8

P5875

Q34514565-696C4426-B067-47D1-84A7-932A39BD59A8

P698

Q34514565-2156A5B4-5B97-42E2-B5F8-3C2846EA102A

P932

Q34514565-AD43CB5A-1FAE-4326-8795-3B90A5E58282

P356

PNAS.0402630101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Protection against lethal influenza virus challenge by RNA interference in vivo

@en

P2093

Chia-Yun Lo

http://www.w3.org/2001/XMLSchema#string

Suzanne L Epstein

http://www.w3.org/2001/XMLSchema#string

P2860

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs

Interference of hepatitis C virus RNA replication by short interfering RNAs

RNA interference

Killing the messenger: short RNAs that silence gene expression

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

Activation of the interferon system by short-interfering RNAs

Immunity to influenza A H9N2 viruses induced by infection and vaccination.

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

Molecular correlates of influenza A H5N1 virus pathogenesis in mice.

P304

8682-8686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0402630101

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Stephen M Tompkins

Terrence M Tumpey

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8532409

http://www.w3.org/2001/XMLSchema#string

P698

15173583

http://www.w3.org/2001/XMLSchema#string

P932

423255

http://www.w3.org/2001/XMLSchema#string